- ホーム
- アプリ分析
- ObvioGo – Clinical Trials
- ObvioGo – Clinical Trials Vs. Nerivio
ObvioGo – Clinical Trials vs Nerivio使用状況と統計
The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT) platform, this app enables participants to engage in clinical studies outside the traditional trial setting—from the comforts of home and as they go about their daily lives. The app’s features allow participants to provide consent, complete study tasks, report changes in health or medication, and communicate with the study team, all from the convenience of their personal iOS.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
Control your Nerivio device and track your migraine headaches.
The Nerivio app controls the Nerivio device - a wireless remote electrical neuromodulation device for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older.
This prescribed device is self-applied to the upper-arm and should be used in the home environment at the onset of migraine headache or aura, or every other day for preventive treatment.
Track your headaches and migraine symptoms in an easy-to-use advanced migraine diary which is included in the app.
To provide you with optimal user experience for managing your migraine, the app may require access to HealthKit for sleep information.
For detailed information on the Nerivio device, please refer to https://nerivio.com/
Nerivio(R) is a prescription device. Use the Nerivio device and this app only if you have a valid prescription and after consulting with your health care professional.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
ObvioGo – Clinical Trials対Nerivioランキング比較
と過去28日間の ObvioGo – Clinical Trials ランキング傾向を比較 Nerivio
ランキング
ご利用可能なデータがありません
ObvioGo – Clinical Trials 対 Nerivio 国の比較によるランキング
と過去28日間の ObvioGo – Clinical Trials ランキング傾向を比較 Nerivio
表示できるデータはありません
無料トライアルで任意のサイトと比較する
ObvioGo – Clinical Trials VS.
Nerivio
12月 23, 2024